Literature DB >> 4177614

Serum fibrin degradation products throughout normal pregnancy.

D G Woodfield, S K Cole, A G Allan, J D Cash.   

Abstract

Fibrin/fibrinogen degradation products in the serum of 169 healthy pregnant and 43 healthy non-pregnant subjects of a similar age group showed a significant increase throughout pregnancy, the highest levels being obtained in the third trimester. There was no correlation with plasma fibrinogen levels or euglobulin lysis times. Though these changes may be due to other alterations in pregnancy not primarily associated with fibrinolysis, it is possible that actual fibrinolysis is not decreased in late pregnancy, as has been previously asssumed.

Mesh:

Substances:

Year:  1968        PMID: 4177614      PMCID: PMC1912815          DOI: 10.1136/bmj.4.5632.665

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  36 in total

1.  Transplacental haemorrhage.

Authors:  J C Woodrow; R Finn
Journal:  Br J Haematol       Date:  1966-05       Impact factor: 6.998

2.  Fibrinolysis and plasminogen levels in pregnancy and the puerperium.

Authors:  A G Shaper; D M Macintosh; C M Evans; J Kyobe
Journal:  Lancet       Date:  1965-10-09       Impact factor: 79.321

3.  The uptake of fibrin and fibrin-degradation products by the isolated perfused rat liver.

Authors:  H Gans; J T Lowman
Journal:  Blood       Date:  1967-04       Impact factor: 22.113

4.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

5.  The fibrinolytic system in human blood during pregnancy.

Authors:  P Brakman
Journal:  Am J Obstet Gynecol       Date:  1966-01-01       Impact factor: 8.661

6.  Idiopathic gangrene in African children.

Authors:  A G Turpie; C D Forbes; G P McNicol
Journal:  Br Med J       Date:  1967-09-09

7.  Peripheral blood flow in normal pregnancy.

Authors:  J Ginsburg; S L Duncan
Journal:  Cardiovasc Res       Date:  1967-04       Impact factor: 10.787

8.  Fibrin degradation products in sera of normal subjects.

Authors:  P C Das; A G Allan; D G Woodfield; J D Cash
Journal:  Br Med J       Date:  1967-12-23

9.  Body composition and energy expenditure during rest and work in pregnancy.

Authors:  J Seitchik
Journal:  Am J Obstet Gynecol       Date:  1967-03-01       Impact factor: 8.661

10.  Effect of moderate exercise on the fibrinolytic system in normal young men and women.

Authors:  J D Cash
Journal:  Br Med J       Date:  1966-08-27
View more
  14 in total

1.  Fibrin deposition in pregnancy.

Authors:  A L Stalker
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

2.  Coagulation disorders.

Authors:  J Bonnar
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1976

3.  Pancreatitis, multiple infarcts and oral contraception.

Authors:  M E Foster; D E Powell
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

Review 4.  Blood clotting and fibrinolysis in pregnancy.

Authors:  P W Howie
Journal:  Postgrad Med J       Date:  1979-05       Impact factor: 2.401

5.  Fibrinolysis in pregnancy.

Authors:  J D Cash
Journal:  Proc R Soc Med       Date:  1971-09

6.  Fibrin degradation products in normal and abnormal pregnancy and parturition.

Authors:  J Bonnar; J F Davidson; C F Pidgeon; G P McNicol; A S Douglas
Journal:  Br Med J       Date:  1969-07-19

7.  Fibrin degradation products.

Authors:  C Merskey; G J Kleiner; W Markus; A J Johnson
Journal:  Br Med J       Date:  1969-10-25

8.  Diagnosis of suspected or occult pulmonary embolus.

Authors:  J D Cash; D G Woodfield; P C Das; A G Allan
Journal:  Br Med J       Date:  1969-05-31

9.  Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes.

Authors:  P C Das
Journal:  J Clin Pathol       Date:  1970-05       Impact factor: 3.411

10.  Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells.

Authors:  P C Das
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.